Press Releases

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2025 on November 1, prior to the opening of trading on the New York Stock Exchange. The company...

Transaction demonstrates Cardinal Health's continued strategic investment in specialty and oncology, underscores commitment to independent community healthcare providers Accelerates the...

In observance of today's World Suicide Prevention Day, Children's Hospital Association (CHA), Cardinal Health (NYSE: CAH), and Zero Suicide Institute (ZSI) celebrate early success of the...

'Warehouse of the Future' to expand nationwide distribution network in support of home healthcare growth DUBLIN, Ohio, Aug. 28, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) officially...

New facility opening in Walton Hills demonstrates ongoing commitment to increase U.S. warehouse capacity and modernize operations DUBLIN, Ohio, Aug. 21, 2024 /PRNewswire/ -- Cardinal Health (NYSE:...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on...

Fourth quarter revenue increased 12% to $59.9 billion Fourth quarter GAAP1 operating earnings were $401 million and GAAP diluted EPS was $0.96 Fourth quarter non-GAAP operating earnings increased...

Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2024 on August 14, prior to the opening of trading on the New York Stock Exchange....

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5056 per share, out of the Company's capital surplus. The dividend...

Revenue increased 9% to $54.9 billion GAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05 Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS...

Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its...

The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will...

Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions...

Study reveals impact of dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability DUBLIN, Ohio, Feb. 29, 2024...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors has elected Robert "Bob" Azelby as an independent director, effective March 1. Mr. Azelby joins the board with over 30 years...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...

Cardinal Health (NYSE: CAH) today released its Fiscal 2023 Environmental, Social and Governance (ESG) Report, highlighting the company's work toward building a healthier, more equitable future....

Revenue increased 12% to $57.4 billion GAAP1 operating earnings were $482 million; GAAP diluted EPS was $1.43 Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS...

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Progress achieved on company's ongoing business and portfolio review Completed review of growth businesses within the Medical Segment: investing in and further developing at-Home Solutions and...

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1, prior to the opening of trading on the New York Stock Exchange. The company...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...

SmartGown™ EDGE is the first pocketed surgical gown designed to help maintain instrument sterility and accessibility. DUBLIN, Ohio, Nov. 9, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH)...

Revenue increased 10% to $54.8 billion GAAP1 operating loss was $14 million and GAAP diluted EPS was $0.02, driven by a Medical segment goodwill impairment Non-GAAP operating earnings increased 35% to

Cardinal Health (NYSE: CAH) has been named among the 100 Best Corporate Citizens, a prestigious annual ranking by 3BL Media that assesses the environmental, social and governance (ESG)...

The next generation in enteral feeding, Kangaroo OMNI™ delivers nutrition and hydration from hospital to home. DUBLIN, Ohio, Sept. 28, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced...

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2024 on November 3, prior to the opening of trading on the New York Stock Exchange. The company...

Cardinal Health Foundation will invest $1.7M to help 14 children's hospitals nationwide prevent youth suicide. DUBLIN, Ohio, Sept. 13, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) in...

The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral...

Fourth quarter revenue increased 13% to $53.5 billion Fourth quarter GAAP1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 Fourth quarter non-GAAP operating earnings...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...

Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2023 on August 15, prior to the opening of trading on the New York Stock Exchange....

New facility is the largest at-Home Solutions has built to date, set to accommodate continued business and home healthcare industry growth DUBLIN, Ohio, June 15, 2023 /PRNewswire/ -- Cardinal...

Narrowing fiscal year 2023 non-GAAP diluted EPS guidance to $5.65 to $5.80, from $5.60 to $5.80 (13% growth at the mid-point)1 Providing preliminary fiscal year 2024 non-GAAP diluted EPS guidance...

Cardinal Health's Outcomes™ business will combine with Transaction Data Systems to offer improved patient engagement and clinical pharmacy solutions, expanding connections between payers and...

Cardinal Health (NYSE: CAH) today launched modern payment solutions, powered by Square, to help independent pharmacies increase operational efficiency, stay current with customer payment...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to the Company's quarterly dividend, to $0.5006 per share, out of the Company's capital surplus. The...

Revenue increased 13% to $50.5 billion GAAP1 operating earnings were $572 million; GAAP diluted EPS was $1.34 Non-GAAP operating earnings increased 11% to $606 million; non-GAAP diluted EPS...

Cardinal Health (NYSE: CAH) announced today the launch of the first-of-its-kind Stray Away™ hair management drape for more efficient surgical procedure preparation. The Stray Away™ drape is...

The new facilities represent Cardinal Health's ongoing commitment to servicing customers, warehousing modernization and growing the local economy DUBLIN, Ohio, April 17, 2023 /PRNewswire/ --...

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2023 on May 4, prior to the opening of trading on the New York Stock Exchange. The company will...

Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This...

Study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments DUBLIN, Ohio, Feb....

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on...

Revenue increased 13% to $51.5 billion GAAP1 operating loss was $119 million due to a non-cash, pre-tax goodwill impairment of $709 million related to the Medical segment; GAAP diluted loss per...

The platform will combine and analyze datasets for live purchasing decision support of pharmaceuticals DUBLIN, Ohio and DENVER, Jan. 26, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced...

Committed to becoming a more sustainable healthcare partner, the company makes meaningful progress in key ESG areas DUBLIN, Ohio, Jan. 25, 2023 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH)...

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2023 on February 2, prior to the opening of trading on the New York Stock Exchange. The company...

Cardinal Health (NYSE: CAH) and its board of directors announced today that Aaron Alt will become the company's new chief financial officer (CFO). Alt will succeed interim CFO, Trish English and...

Cardinal Health (NYSE: CAH) released today its latest edition of Oncology Insights, a biannual, research-based report from Cardinal Health. Featuring perspectives from nearly 200 oncologists...

Launching as a pilot with Medically Home, new technology offering will reach patients in one to two hours DUBLIN, Ohio, Nov. 15, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on...

Revenue increased 13% to $49.6 billion GAAP1 operating earnings were $137 million, GAAP diluted EPS were $0.40 Non-GAAP operating earnings decreased 20% to $423 million due to a decline in Medical...

Today, Cardinal Health (NYSE: CAH) released its third edition of Rheumatology Insights, a research report based on surveys with more than 100 rheumatologists nationwide that focuses on key trends...

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2023 on November 4, prior to the opening of trading on the New York Stock Exchange. The company...

--Victor Crawford will step down as CEO of Pharmaceutical Segment-- --Debbie Weitzman, President of Pharmaceutical Distribution, named CEO of Pharmaceutical Segment-- DUBLIN, Ohio, Sept. 8, 2022...

Adds Four New Independent Directors to the Board Forms New Business Review Committee to Evaluate Portfolio and Operations DUBLIN, Ohio, Sept. 6, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH)...

Revenue increased 11% to $47.1 billion in the fourth quarter GAAP1 operating earnings were $36 million in the fourth quarter; GAAP diluted EPS were $0.50 in the fourth quarter Non-GAAP operating...

-- Mike Kaufmann to Step Down as Chief Executive Officer and from Board of Directors -- -- Jason Hollar, Chief Financial Officer, Named Chief Executive Officer -- -- Patricia English to Serve as...

Greene previously served as SVP of EIT for the company's Pharmaceutical Segment DUBLIN, Ohio, Aug. 1, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that Michelle Greene has been...

TO: ALL PERSONS AND ENTITIES THAT HELD CARDINAL HEALTH, INC. COMMON STOCK AS OF THE CLOSE OF TRADING ON MAY 25, 2022 AND THAT CONTINUE TO HOLD CARDINAL HEALTH COMMON STOCK AS OF THE CLOSE OF...

Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2022 on August 11, prior to the opening of trading on the New York Stock Exchange....

Strengthening Cornerstone Rheumatology™ GPO as a leading rheumatology-focused GPO by providing innovative solutions and robust specialty drug access to over 1,300 rheumatology providers nationwide.

Cardinal Health (NYSE: CAH) today announced the launch of an inventory reserve program that helps labs and health systems more accurately pre-order respiratory diagnostics before the onset of...

Research shows stress leading oncologists to consider leaving the field, retiring or selling their practice DUBLIN, Ohio, June 3, 2022 /PRNewswire/ -- Nearly 90% of oncologists said they...

New facility to operate state-of-the-art warehouse technology, while creating new jobs DUBLIN, Ohio, June 2, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the addition of a new...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on...

DUBLIN, Ohio — May 9, 2022— Cardinal Health (NYSE:CAH) and URAC, the nation’s largest independent health care accreditation organization, announced today an agreement to help customers of...

Revenue increased 14% to $44.8 billion GAAP1 operating loss was $97 million due to a non-cash, pre-tax goodwill impairment of $474 million in the Medical segment; GAAP diluted loss per share was $5.05

CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas, May 3, 2022—(BUSINESS WIRE)—AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have...

Cardinal Health (NYSE: CAH) today announced the winners and honorees of its annual Lab Excellence List, which names top clinical laboratory professionals making significant contributions to health...

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2022 on May 5 prior to the opening of trading on the New York Stock Exchange. The company will...

Cardinal Health (NYSE: CAH) today announced plans to build a 574,670 square foot medical distribution center in the Columbus, Ohio area. The new building will integrate automation and technology...

Nearly 600 clinicians participated in a first-of-its-kind global consensus process supported by a grant from Cardinal Health; key findings include recommendation for use of mechanical compression...

The incise drape is the first to feature Avery Dennison's patented BeneHold™ CHG adhesive technology DUBLIN, Ohio, March 17, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched the...

46 of 49 Eligible States and Over 90 Percent of Litigating Political Subdivisions Participate CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC),...

Today Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, and Cardinal Health (NYSE: CAH) announced expanded distribution of Cue's professional use and over-the-counter COVID-19...

Cardinal Health (NYSE: CAH) has been recognized by Forbes as one of America's Best Large Employers 2022, a list of more than 500 public and private corporations, hospitals, universities and more,...

Cardinal Health (NYSE: CAH) today announced it will leverage the Kinaxis® RapidResponse® platform to increase medical product visibility and supply chain agility. Kinaxis will enhance Cardinal...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on April 15, 2022 to shareholders of record...

Today Cardinal Health published its 2022 Biosimilars Report: The U.S. Journey and Path Ahead, a publication that brings together the latest industry data on biosimilar utilization and payer...

Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2022 revenues of $45.5 billion, an increase of 9% from the second quarter of last year. Second quarter GAAP operating loss was...

Cardinal Health again has earned the perfect score of 100% on the Human Rights Campaign Foundation's Corporate Equality Index (CEI), a national benchmarking tool to measure corporate policies and...

Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global Medical Response (GMR) and Cardinal Health who will each...

Cardinal Health (NYSE: CAH) today provided a fiscal year 2022 financial update for the Medical segment. The company now expects additional inflationary impacts and lower volumes resulting...

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2022 on February 3 prior to the opening of trading on the New York Stock Exchange. The company...

CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)-- AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that the deadline for...

Melbourne (Australia) and Indianapolis, IN (U.S.A.) – 20 December 2021. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the...

Cardinal Health today announced its business, WaveMark™ Supply Management and Workflow Solutions, will now be available for implementation in clinical labs across the U.S. "WaveMark is among the...

Kannapolis, NC—Nov. 16, 2021 – Cardinal Health (NYSE: CAH) and Zipline, the global leader in instant logistics, today announced a collaboration to offer on-demand autonomous aircraft delivery...

Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on January 15, 2022 to shareholders of...

Cardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE) study as part...

Paoli, PA — Cardinal Health Specialty Solutions and Gastrologix, the only gastroenterology (GI)-specific group purchasing organization (GPO) in the United States, working in conjunction with the...

Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD), today...